Literature DB >> 15114091

The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.

Marlies K A Dankers1, Marian D Witvliet, Dave L Roelen, Peter de Lange, Nelleke Korfage, Guido G Persijn, René Duquesnoy, Ilias I N Doxiadis, Frans H J Claas.   

Abstract

BACKGROUND: The correlation between antibody production against mismatched donor human leukocyte antigens (HLA) and the number of amino acid sequence mismatches was analyzed in patients who rejected a kidney transplant (n=146).
METHODS: A similar analysis was performed for the antibody production of women against the paternal HLA antigens of their child (n=1,397). The amino acid sequence (triplet) differences were analyzed using the HLAMatchmaker algorithm.
RESULTS: In both groups, a positive correlation was found between the number of triplet mismatches and the percentage of individuals producing antibodies (P <0.0001). If zero triplet mismatches were present, no antibodies were formed in all cases. When 11 or 12 triplet mismatches were present, 94% of the transplant patients produced antibodies against the donor. In pregnancy, 11 or 12 triplet mismatches led to 27% of the women producing specific antibodies.
CONCLUSIONS: These results indicate that the immunogenicity of the fetus is lower than that of a rejected kidney and that analysis of the number of triplet mismatches can predict the antibody reactivity against the mismatched HLA antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114091     DOI: 10.1097/01.tp.0000120385.03278.28

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  33 in total

1.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

Review 2.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

Review 4.  Precision Transplant Medicine: Biomarkers to the Rescue.

Authors:  Maarten Naesens; Dany Anglicheau
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

5.  The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.

Authors:  Ankit Sharma; Anne Taverniti; Nicole Graf; Armando Teixeira-Pinto; Joshua R Lewis; Wai H Lim; Stephen I Alexander; Anne Durkan; Jonathan C Craig; Germaine Wong
Journal:  Pediatr Nephrol       Date:  2020-02-17       Impact factor: 3.714

6.  Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

Authors:  Rene J Duquesnoy; Yehia Awadalla; Jon Lomago; Larry Jelinek; Judy Howe; Dwayne Zern; Betty Hunter; Joan Martell; Alin Girnita; Adriana Zeevi
Journal:  Transpl Immunol       Date:  2007-10-30       Impact factor: 1.708

7.  Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

Authors:  Marilyn Marrari; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

8.  BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

Authors:  Sebastiaan Heidt; Kathryn J Wood
Journal:  Expert Opin Med Diagn       Date:  2012-07

9.  HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.

Authors:  Wai H Lim; Jeremy R Chapman; Patrick T Coates; Joshua R Lewis; Graeme R Russ; Narelle Watson; Rhonda Holdsworth; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-31       Impact factor: 8.237

10.  HLA antibody testing: a tool to facilitate not to prevent organ transplantation.

Authors:  Frans H J Claas
Journal:  Int J Immunogenet       Date:  2008-08       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.